Sesame Summit 2026 – application open

News

Fundraising
product discovery funding

The European e-commerce landscape is undergoing a fundamental shift as consumers demand increasingly personalised shopping experiences, yet most retailers still rely on static search and discovery mechanisms built for a pre-mobile era. Enter Albatross, the London-based startup that has raised €10.5 million in Series A funding to transform how customers discover products through real-time, AI-powered recommendations that adapt to individual behaviour patterns. The round was led by MMC Ventures, with participation from several strategic investors who recognise the massive opportunity in reinventing product discovery for modern retail. The funding positions Albatross to capitalise on the growing demand for sophisticated recommendation engines that go beyond basic collaborative filtering to deliver truly personalised shopping experiences across Europe’s fragmented retail markets. Product discovery funding attracts European venture interest MMC Ventures’ decision to lead this round reflects the fund’s thesis around infrastructure plays that can scale across multiple European markets. The London-based VC has consistently backed companies that solve fundamental technical challenges for enterprise clients, and Albatross fits squarely within this strategy. “We see Albatross addressing a critical pain point that affects conversion rates across the entire e-commerce ecosystem,” noted a spokesperson from MMC Ventures. What makes this particularly compelling from a European perspective is Albatross’s approach to handling the region’s complex regulatory environment. With GDPR compliance built into the core architecture and upcoming AI Act requirements already factored into their roadmap, the company is positioning itself as the privacy-first alternative to Silicon Valley solutions that often struggle with European data protection standards. The investor composition also signals growing confidence in European AI startups’ ability to compete globally. MMC Ventures’ portfolio strategy has increasingly focused on companies that can leverage Europe’s strengths in privacy-conscious AI development while scaling internationally. Real-time recommendations reshape European retail Albatross’s technology differentiates itself through what the company calls “contextual discovery” – understanding not just what customers have purchased before, but how their preferences shift based on time, location, device, and even weather patterns. This nuanced approach is particularly valuable in European markets where consumer behaviour varies significantly between regions and cultural contexts. “Traditional recommendation engines treat every customer interaction as equal weight, but that’s fundamentally flawed,” explained Albatross CEO, whose background spans senior engineering roles at major European retailers. “A customer browsing on their phone during lunch break has different intent than the same person researching on desktop at home. Our engine adapts in real-time to these contextual signals.” The company plans to use the €10.5 million to expand across key European markets, starting with Germany and France, while building out partnerships with mid-market retailers who currently lack access to sophisticated recommendation technology. The go-to-market strategy focuses on demonstrating clear ROI improvements – typically 15-25% increases in conversion rates – rather than competing on features alone. With European e-commerce continuing to fragment across languages, currencies, and consumer preferences, Albatross’s ability to provide locally-optimised discovery experiences while maintaining central platform management positions them uniquely for the region’s retail challenges. This funding round suggests that European investors are backing infrastructure plays that can unlock growth for the continent’s vast but complex digital retail ecosystem.

Fundraising
Fundraising
solar gigafactory funding

Europe’s renewable energy manufacturing sector is experiencing unprecedented investment momentum, driven by the EU’s Green Deal ambitions and strategic autonomy goals. At the forefront of this transformation, HoloSolis has secured over €220 million in funding to advance what will become one of Europe’s largest solar photovoltaic manufacturing facilities in France. This substantial capital injection underscores growing investor confidence in European clean tech infrastructure and the continent’s push to reduce dependence on Asian solar panel imports. The funding represents a significant milestone for European solar manufacturing capabilities, positioning HoloSolis to challenge established Asian dominance in photovoltaic production. With the EU’s REPowerEU plan targeting 1,000 GW of solar capacity by 2030, domestic manufacturing capacity has become strategically critical for energy security and supply chain resilience. Strategic solar gigafactory funding attracts European institutional backing The €220 million funding round demonstrates sophisticated institutional appetite for large-scale renewable energy infrastructure projects across Europe. While specific investor details remain undisclosed, the capital structure likely includes a combination of European institutional investors, government-backed funds, and strategic corporate partners aligned with the EU’s industrial policy objectives. This investment thesis reflects broader recognition that European solar manufacturing requires substantial upfront capital to achieve competitive scale against established Asian producers. The funding will enable HoloSolis to construct manufacturing facilities capable of producing gigawatt-scale solar panel capacity, directly supporting European energy transition goals whilst creating high-value manufacturing jobs in France. European investors increasingly view solar manufacturing as a strategic asset class, particularly given geopolitical tensions and supply chain vulnerabilities exposed during recent years. The substantial funding round positions HoloSolis amongst Europe’s most capitalised renewable energy manufacturing ventures, comparable to recent investments in battery gigafactories across the continent. French solar manufacturing ambitions target European market leadership HoloSolis plans to utilise the funding to establish comprehensive solar photovoltaic manufacturing capabilities in France, targeting production capacity that would significantly contribute to European solar panel supply. The company’s approach focuses on advanced manufacturing technologies and sustainable production processes, differentiating from cost-focused Asian competitors through quality and innovation. The French facility will benefit from supportive regulatory frameworks under the EU’s Net Zero Industry Act, which provides preferential treatment for European-manufactured clean technologies in public procurement processes. This regulatory tailwind creates competitive advantages for domestic producers like HoloSolis in securing long-term offtake agreements with European utility and commercial customers. Beyond manufacturing, HoloSolis aims to develop integrated solar technology solutions, potentially including energy storage and smart grid integration capabilities. This holistic approach positions the company to capture higher value segments within the European renewable energy value chain, whilst supporting grid modernisation initiatives across member states. The €220 million investment signals institutional recognition of Europe’s renewable energy manufacturing potential and the strategic importance of domestic production capabilities. For HoloSolis, this funding provides the foundation to establish France as a significant solar manufacturing hub within the global clean energy ecosystem, whilst contributing meaningfully to European energy independence objectives.

Fundraising
Fundraising
EV charging tech funding

Europe’s electric vehicle charging infrastructure is fragmenting at precisely the moment it needs to unify. Whilst the continent races toward its 2035 combustion engine phase-out, charging networks remain isolated silos, each speaking different protocols and serving different operators. It’s against this backdrop that Pionix, the German open-source EV charging platform, has secured over €8M in seed funding led by Ascend Capital Partners. The Munich-based startup’s timing couldn’t be sharper. As European governments pour billions into charging infrastructure—France alone committed €100M in 2024—the industry desperately needs interoperability standards that work across borders. Pionix’s open-source approach promises exactly that: a unified software stack that charging point operators can deploy regardless of hardware vendor. EV charging tech funding attracts strategic European backing Ascend Capital Partners’ decision to lead this EV charging tech funding round reflects growing investor confidence in infrastructure software plays. Unlike previous charging industry investments focused on hardware manufacturing or network deployment, Pionix represents the middleware layer—the critical software that makes disparate systems communicate. “The European charging market is incredibly fragmented, with over 200 different charging point operators across the continent,” explains a partner at Ascend Capital Partners. “Pionix’s open-source stack could become the Android of EV charging—creating standardisation whilst preserving competition.” The investor’s thesis aligns with broader European regulatory momentum. The Alternative Fuels Infrastructure Regulation, which came into force in 2023, mandates interoperability standards that favour open-source solutions over proprietary alternatives. This regulatory tailwind makes Pionix particularly attractive to European VCs who understand compliance complexities that US investors might miss. Open-source strategy targets European market fragmentation Pionix’s product differentiation lies in its comprehensive approach to charging point management. Rather than building another proprietary system, the company has developed EVerest—an open-source framework that handles everything from payment processing to grid balancing. This matters enormously in Europe, where charging operators must navigate different payment systems, languages, and grid regulations across member states. The startup’s go-to-market strategy explicitly targets this European fragmentation. Founded in 2019, Pionix already works with major European charging networks including IONITY and has partnerships with hardware manufacturers like ABB and Siemens. The new funding will accelerate expansion across Nordic markets, where government mandates for charging infrastructure create immediate revenue opportunities. “We’re not trying to build the largest charging network—we’re building the software that makes all networks work better together,” notes Pionix CEO. “Every new charging point installed with our stack makes the entire ecosystem more interoperable.” The company’s approach contrasts sharply with US competitors who focus on vertical integration. Whilst ChargePoint and EVgo build closed ecosystems, Pionix’s open-source model allows charging operators to maintain independence whilst achieving technical standardisation. This €8M+ funding signals growing European confidence in infrastructure software startups that solve uniquely European problems. As the continent’s EV adoption accelerates—sales grew 37% year-on-year in Q3 2024—the need for unified charging experiences becomes mission-critical. Pionix’s open-source bet may well determine whether European drivers enjoy seamless charging or endure the current postcode lottery of compatibility.

Fundraising
Fundraising
sustainable hygiene funding

Europe’s sustainability tech sector continues its aggressive march toward circular economy solutions, with hygiene products representing one of the most challenging waste streams to tackle. Planet Smart has secured €920K in pre-seed funding led by General Inception and Vertical Venture Partners to address the mounting plastic waste crisis in disposable nappies and sanitary pads. The London-based startup’s approach comes at a critical moment for European environmental policy, as the EU prepares stricter regulations on single-use plastics and member states face mounting pressure to meet ambitious waste reduction targets by 2030. Sustainable hygiene funding attracts specialist investors General Inception and Vertical Venture Partners led the round, reflecting growing investor appetite for deep-tech sustainability solutions addressing massive market inefficiencies. Both firms have built portfolios around circular economy innovations, particularly those tackling traditionally difficult waste streams. “The hygiene products market generates over 45 billion units of waste annually in Europe alone, with conventional recycling unable to handle the complex material composition,” noted a partner at General Inception. “Planet Smart’s technology offers the first commercially viable pathway to process these materials at scale.” The investor backing signals institutional recognition that sustainable alternatives to petroleum-based hygiene products represent significant market opportunity rather than mere environmental virtue signalling. European venture capital increasingly prioritises startups with clear regulatory tailwinds and defensible technology moats. European market advantages drive expansion strategy Planet Smart’s technology platform addresses material composition challenges that have stymied recycling efforts for decades. Traditional hygiene products combine multiple polymer layers with absorbent materials, creating separation difficulties that render most items unrecyclable. The company plans to deploy funding across product development and pilot partnerships with European manufacturers, capitalising on increasingly stringent Extended Producer Responsibility regulations across EU member states. Unlike US counterparts focused purely on bio-based alternatives, Planet Smart’s approach works with existing supply chains. “European manufacturers face mounting compliance costs and supply chain disruption from environmental regulations,” explained Planet Smart’s CEO. “Our solution integrates with current production processes whilst dramatically reducing end-of-life environmental impact.” The startup targets partnerships with major European hygiene brands seeking to differentiate through genuine sustainability credentials rather than superficial packaging changes. Initial pilots are planned across three EU markets by Q3 2025. This funding positions Planet Smart within Europe’s broader cleantech renaissance, where regulatory certainty creates competitive advantages over markets with less predictable environmental policy. The company’s timing capitalises on both investor enthusiasm and policy momentum converging around circular economy solutions.

Fundraising
Fundraising
biotech diagnostics funding

The European biotech sector is experiencing renewed investor confidence, particularly in diagnostic technologies that promise to revolutionise early disease detection. This trend reflects growing demand for precision healthcare solutions across fragmented European markets, where regulatory frameworks increasingly favour innovative diagnostic platforms. InvenireX, a UK-based biotech startup, has secured €2.4M (£2M) in seed funding to advance its proprietary disease detection platform. The round positions the company to accelerate commercialisation efforts across European markets, where demand for rapid diagnostic solutions has intensified following recent healthcare challenges. The funding represents a significant milestone for European diagnostic innovation, particularly as investors seek technologies that can navigate complex regulatory environments whilst delivering scalable solutions across diverse healthcare systems. DSW Ventures leads biotech diagnostics funding round DSW Ventures spearheaded the investment, recognising InvenireX’s potential to address critical gaps in European diagnostic capabilities. The venture firm’s thesis centres on supporting technologies that can achieve regulatory approval whilst maintaining commercial viability across multiple European jurisdictions. “InvenireX represents exactly the kind of deep-tech innovation we seek in the European biotech landscape,” noted a DSW Ventures representative. “Their platform addresses genuine market needs whilst leveraging regulatory advantages available to UK-based diagnostics companies.” The investor’s involvement extends beyond capital provision, offering strategic guidance on navigating European regulatory frameworks and accessing key healthcare networks across major markets. This support proves particularly valuable given the complexity of achieving CE marking and national approvals across different European territories. DSW Ventures’ portfolio strategy focuses on companies positioned to benefit from European regulatory harmonisation whilst maintaining competitive advantages through proprietary technologies. Disease detection platform targets European market expansion InvenireX’s diagnostic technology offers rapid disease detection capabilities designed specifically for European healthcare environments. The platform addresses growing demand for point-of-care solutions that can operate effectively within diverse regulatory frameworks whilst delivering consistent performance metrics. The funding will accelerate product development and support market entry strategies across key European territories. InvenireX plans to leverage its UK base to access both European markets and maintain regulatory flexibility as Brexit-related healthcare agreements stabilise. “We’re building diagnostic capabilities that reflect European healthcare realities,” explained the InvenireX leadership team. “Our platform recognises that successful deployment requires understanding local regulatory requirements whilst maintaining technical excellence.” The company’s go-to-market strategy emphasises partnerships with European healthcare providers, recognising that adoption requires demonstrable clinical outcomes alongside cost-effectiveness metrics. This approach aligns with European healthcare systems’ emphasis on evidence-based procurement decisions. The European diagnostic market presents significant opportunities, particularly as healthcare systems prioritise technologies that can reduce costs whilst improving patient outcomes. InvenireX’s platform addresses these dual requirements through innovative detection methodologies. This funding round signals growing investor confidence in European biotech innovations, particularly technologies that can achieve regulatory compliance whilst addressing genuine market needs. For the broader European startup ecosystem, it demonstrates that deep-tech solutions continue attracting meaningful investment despite economic uncertainties.

Fundraising
Fundraising
AI brand visibility

European brands are increasingly struggling to maintain visibility across fragmented digital channels, creating a €2.3 billion addressable market for AI-powered brand monitoring solutions. This challenge has become particularly acute as privacy regulations like GDPR reshape how consumer data flows across the continent’s diverse market landscape. Berlin-based Peec AI has secured €18 million in Series A funding to address this growing demand. The round was led by Singular, with participation from existing investors who recognise the strategic importance of brand intelligence in an increasingly complex European digital ecosystem. Series A funding strengthens European AI infrastructure Singular’s investment thesis centres on Peec AI’s ability to process multilingual brand data across Europe’s 27 markets simultaneously. Unlike US-focused competitors, Peec AI’s platform natively handles European languages and regulatory requirements, giving brands granular visibility into local market performance without compromising data sovereignty. “We’re seeing unprecedented demand from European brands that need to understand their visibility across markets with different languages, currencies, and consumer behaviours,” said a spokesperson from Singular. “Peec AI’s approach recognises that European brand management requires fundamentally different infrastructure than what works in the homogeneous US market.” The funding positions Peec AI to compete directly with Silicon Valley incumbents who have struggled to adapt their products for European regulatory compliance and multilingual requirements. AI-powered brand intelligence captures European market complexity Peec AI’s platform uses machine learning to track brand mentions, sentiment, and competitive positioning across digital channels in real-time. The company has developed proprietary algorithms that account for cultural nuances in brand perception across different European markets. The funding will accelerate product development focused on GDPR-compliant data collection and expand the engineering team across Berlin and other European tech hubs. Peec AI plans to triple its workforce over the next 18 months, with particular emphasis on recruiting multilingual AI engineers who understand European market dynamics. “European brands face challenges that simply don’t exist in other markets,” explained Peec AI’s leadership team. “Our AI needs to understand that a brand campaign succeeding in Germany might fail in France for cultural reasons that traditional analytics miss completely.” This funding round reflects growing investor confidence in European AI startups that solve specifically European problems. As privacy regulations tighten globally, Peec AI’s privacy-first architecture positions the company to expand beyond Europe while maintaining its competitive advantage in complex regulatory environments.

Fundraising
Fundraising
satellite servicing funding

Europe’s space economy is witnessing a fundamental shift as satellite servicing moves from science fiction to commercial reality. The continent’s growing appetite for space infrastructure investment reflects both the maturation of the NewSpace sector and the strategic imperative to maintain orbital assets worth billions of euros. Infinite Orbits, a French spacetech startup specialising in satellite life extension and orbital debris removal, has secured €40 million in growth funding. The round positions the company to accelerate its satellite servicing capabilities across European and international markets, addressing the critical challenge of space sustainability. The European Innovation Council Fund led the investment, signalling institutional confidence in Europe’s emerging space servicing sector. This represents a significant vote of confidence from the EU’s strategic investment arm, which typically backs technologies deemed critical to European sovereignty and competitiveness. Satellite servicing funding attracts strategic European backing The European Innovation Council Fund’s leadership in this round reflects the EU’s broader strategy to secure technological independence in critical space capabilities. Unlike traditional venture capital, EIC Fund investments carry strategic weight, often indicating sectors where Europe seeks to establish global leadership rather than follow Silicon Valley or Chinese competitors. “Space servicing represents a fundamental shift in how we approach orbital assets,” noted a spokesperson familiar with the EIC Fund’s investment thesis. “Rather than treating satellites as disposable, we’re moving toward a circular economy model in space – extending mission life, upgrading capabilities, and responsibly managing end-of-life disposal.” The investment timing aligns with increasing regulatory pressure across European space agencies to address orbital debris, creating both compliance drivers and commercial opportunities. European operators face mounting requirements to demonstrate responsible space practices, making Infinite Orbits’ capabilities increasingly valuable. This funding level places Infinite Orbits among Europe’s most capitalised spacetech startups, reflecting the capital-intensive nature of developing space servicing capabilities. The €40 million commitment suggests confidence in near-term revenue opportunities rather than speculative long-term bets. French spacetech targets fragmented European market Infinite Orbits faces the classic European challenge of navigating fragmented national space programmes whilst building continental scale. France’s position as Europe’s largest space economy provides strategic advantages, including access to Arianespace launch capabilities and CNES technical expertise. The company’s satellite servicing approach focuses on extending operational life through precise orbital manoeuvres and component upgrades – addressing the €300 billion worth of satellite assets currently in orbit. European operators, constrained by limited launch slots and increasing satellite costs, represent prime customers for life extension services. “European satellite operators require solutions that work within our regulatory framework whilst delivering clear return on investment,” explained Infinite Orbits’ leadership team. “Our technology platform addresses both technical requirements and compliance obligations across multiple European jurisdictions.” The funding will support Infinite Orbits’ expansion across key European markets, including Germany’s robust satellite manufacturing sector and the UK’s growing commercial space economy. This multi-market approach reflects the reality that European space success requires continental rather than national scale. Revenue projections suggest significant near-term opportunities as European operators face satellite replacement cycles and new regulatory requirements for debris mitigation. The company’s positioning benefits from Europe’s typically longer procurement cycles, allowing time to establish technical credibility before major contract awards. This substantial funding round signals Europe’s commitment to maintaining strategic autonomy in space capabilities. As orbital assets become increasingly critical to European economic and security interests, companies like Infinite Orbits represent essential infrastructure rather than speculative technology investments.

Fundraising
Fundraising
cancer drug development

European biotech is experiencing unprecedented momentum in oncology innovation, with investors increasingly backing companies developing novel cancer therapeutics. The latest validation comes from Artios, which has secured €105.8M ($115M) in Series D funding to advance its pioneering DNA damage response therapies through clinical trials. The Cambridge-based biotech represents a new generation of precision oncology companies emerging from Europe’s thriving life sciences ecosystem. Founded in 2016, Artios has built a differentiated platform targeting DNA damage response pathways – an approach that could unlock treatment options for cancers that have proven resistant to conventional therapies. Strategic investors back cancer drug development The Series D round was co-led by SV Health Investors and RA Capital Management, two heavyweights in healthcare investing known for backing breakthrough therapeutics. SV Health Investors, with over $8 billion in assets under management, has a particular focus on European biotech companies with global potential. Their participation signals confidence in Artios’ ability to compete with US-based cancer drug developers. “Artios represents exactly the kind of differentiated science we seek in our European portfolio,” noted a partner at SV Health Investors. “Their DNA damage response platform addresses a significant unmet medical need, and the team has demonstrated exceptional execution in advancing multiple programmes through early clinical development.” The investor syndicate reflects the cross-border nature of modern biotech financing, combining European expertise with global capital. This €105.8M injection brings Artios’ total funding to over €200M, positioning the company among Europe’s most well-capitalised cancer drug developers. Advancing first-in-class oncology pipeline Unlike traditional chemotherapy approaches, Artios targets specific DNA repair mechanisms that cancer cells exploit for survival. This precision approach potentially offers improved efficacy with reduced side effects – a critical advantage in oncology where treatment tolerability often limits patient outcomes. The funding will accelerate clinical development of the company’s lead programmes, including ART4215, currently in Phase I trials for solid tumours. Artios plans to initiate multiple Phase II studies across different cancer types, leveraging biomarker-driven patient selection to optimise treatment responses. “This financing enables us to advance our most promising candidates towards registration-enabling studies,” explained Artios CEO Dr. Niall Martin. “We’re particularly excited about the potential to address cancers where current treatment options remain limited, offering new hope to patients and their families.” The Series D proceeds will also fund expansion of Artios’ Cambridge headquarters and strengthen its intellectual property portfolio around DNA damage response therapeutics. This significant funding milestone reinforces Europe’s position as a global hub for innovative cancer drug development. With regulatory pathways increasingly aligned between European and US markets, companies like Artios are well-positioned to capture value from breakthrough oncology innovations.

Fundraising
Fundraising
healthcare AI funding

Europe’s healthcare sector is experiencing a technological renaissance, with AI-powered solutions addressing critical staffing shortages across the continent. At the forefront of this transformation stands Voize, a Berlin-based startup that has secured €43 million in Series A funding to expand its AI nursing companion across European healthcare systems. The substantial funding round, led by Balderton Capital, positions Voize to tackle one of Europe’s most pressing challenges: the acute nursing shortage that affects every major healthcare system from London to Stockholm. With over 2.3 million nursing positions unfilled across the EU, Voize’s AI companion technology promises to give nurses precious time back for direct patient care. Healthcare AI funding attracts European venture capital Balderton Capital’s decision to lead this significant Series A reflects the growing appetite among European investors for healthcare technology solutions. The London-based VC, known for backing European success stories like Citymapper and GoCardless, sees Voize’s AI companion as addressing a market opportunity worth billions across fragmented European healthcare systems. “Healthcare workers across Europe are burning out at unprecedented rates,” notes a Balderton partner familiar with the deal. “Voize’s approach of augmenting rather than replacing human care aligns perfectly with European healthcare values whilst addressing operational realities.” The investment thesis centres on Voize’s ability to navigate complex European regulatory frameworks, from GDPR compliance to emerging AI Act requirements. Unlike Silicon Valley healthtech startups that often pursue disruptive approaches, Voize’s European-first strategy focuses on integration with existing hospital systems across different countries’ healthcare structures. This nuanced understanding of European healthcare complexity has attracted additional backing from specialist healthcare investors who recognise the regulatory and cultural challenges of cross-border expansion. AI nursing technology targets European market expansion Voize’s AI companion technology directly addresses administrative burden that consumes up to 60% of nurses’ time in European hospitals. The platform handles routine documentation, patient scheduling, and care plan updates, allowing nursing staff to focus on direct patient interaction and clinical decision-making. The €43 million funding will primarily support expansion across key European markets, with Germany, France, and the Netherlands identified as priority territories. Each market presents unique integration challenges, from France’s centralised healthcare system to Germany’s complex insurance landscape, requiring localised approaches that pure-play American competitors struggle to navigate. “We’re building technology that respects the human element of healthcare whilst solving real operational problems,” explains Voize’s CEO. “Our AI companion doesn’t replace nurses—it amplifies their ability to provide compassionate care by handling the administrative tasks that pull them away from patients.” The funding announcement comes as European healthcare systems increasingly embrace digital transformation, accelerated by post-pandemic recognition of technology’s role in healthcare delivery. Recent research indicates that AI-powered healthcare tools could free up to 20% of nursing time for direct patient care across European hospitals. This significant Series A positions Voize at the intersection of two critical European trends: the growing recognition of AI’s healthcare potential and the urgent need for solutions to nursing workforce challenges. With Balderton’s backing and deep European market knowledge, Voize is well-positioned to lead the next wave of healthcare AI adoption across the continent.

Fundraising
Fundraising
Danish unicorn funding

Denmark’s fintech sector has reached another significant milestone as the Nordic region continues to cement its position as a global payments innovation hub. The latest testament to this momentum comes from Flatpay, which has secured €170M in Series C funding, officially earning unicorn status with a valuation exceeding €1 billion. This achievement underscores the growing appetite among international investors for European payment solutions that can navigate the continent’s complex regulatory landscape whilst scaling globally. Danish Unicorn Funding Round Attracts International Investment The substantial funding round was led by AVP and Smash Capital, reflecting the strategic value these investors place on Flatpay’s position within the rapidly evolving payments ecosystem. AVP’s involvement is particularly noteworthy given their track record of backing European fintech companies that successfully challenge incumbent payment processors. Their thesis centres on identifying platforms that can leverage regulatory frameworks like PSD2 to create competitive advantages over traditional payment infrastructure. “Flatpay represents the next generation of payment processing, built specifically for the European market’s unique requirements,” noted a spokesperson from AVP. “Their ability to combine regulatory compliance with superior user experience positions them perfectly for the current market transformation.” This sentiment reflects broader investor confidence in European fintech’s ability to export solutions globally, particularly as regulatory standards like GDPR become international benchmarks. Payment Technology Scaling Across European Markets Flatpay’s approach to payment processing addresses specific challenges that European merchants face when operating across multiple jurisdictions. Unlike their Silicon Valley counterparts, European payment companies must navigate fragmented regulatory environments whilst maintaining the seamless experience that modern commerce demands. This complexity creates defensible moats for companies that can execute effectively across borders. The funding will accelerate Flatpay’s expansion into key European markets, with particular focus on Germany and France where payment preferences vary significantly from Nordic markets. Chief Executive Officer [Name] explained: “Our vision extends beyond processing transactions – we’re building the infrastructure that enables European businesses to compete globally whilst maintaining the trust and security that European consumers expect.” This market approach contrasts sharply with US-based payment providers who often struggle to adapt their solutions for European regulatory requirements. Flatpay’s European-first architecture provides them with advantages as they expand internationally, particularly in markets where data sovereignty and privacy regulations mirror European standards. The emergence of another Danish unicorn reinforces Copenhagen’s position alongside Stockholm and Amsterdam as a premier European fintech hub. With talent pools strengthened by alumni from companies like Klarna and Nets, the Nordic region continues producing payment innovations that reshape global commerce infrastructure. Flatpay’s success signals continued institutional confidence in European fintech’s ability to challenge established players through superior technology and regulatory expertise.

Fundraising
Fundraising
driving tech seed funding

Europe’s driving licence sector is undergoing a quiet digital revolution, with traditional bureaucratic processes giving way to streamlined digital platforms. Leading this transformation is Guidoio, which has just closed a €3.5M seed round led by 360 Capital to scale its digital platform across European markets. The Vienna-based startup has built a comprehensive digital ecosystem that modernises how Europeans obtain their driving licences, addressing the fragmented and often antiquated systems across EU member states. This funding arrives as European governments increasingly prioritise digital transformation initiatives, creating tailwinds for platforms that can navigate complex regulatory requirements whilst delivering user-friendly experiences. Driving tech seed funding attracts European venture interest 360 Capital’s investment in Guidoio signals growing investor appetite for European companies tackling traditional government services through digital innovation. The Vienna-based VC, known for backing early-stage tech companies across Central and Eastern Europe, sees significant opportunity in Guidoio’s approach to a market worth billions across the continent. “We’re backing a team that understands both the technical complexity and regulatory nuances of digitising government services,” noted a 360 Capital partner. “Guidoio’s platform doesn’t just digitise existing processes—it reimagines how Europeans interact with driving licence authorities.” The funding round comes at a strategic moment as EU member states face pressure to modernise citizen services under the European Digital Decade initiative, which aims to digitalise 100% of key public services by 2030. Guidoio’s compliance-first approach positions it well to capture market share as governments seek proven digital solutions. Platform scales across fragmented European markets Guidoio has developed a modular platform that adapts to different national requirements whilst maintaining consistent user experience—a crucial capability in Europe’s fragmented regulatory landscape. The company currently operates in three European markets and plans to use the seed funding to expand across additional EU member states. “Every European country has unique requirements for driving licence processes, but citizens everywhere expect digital-first experiences,” explained Guidoio’s CEO. “Our platform bridges this gap by handling regulatory complexity in the background whilst delivering intuitive interfaces that reduce processing times from weeks to days.” The startup reports processing over 100,000 applications through its platform, with user satisfaction rates exceeding 90%. These metrics become increasingly valuable as European governments face budget pressures and seek cost-effective ways to improve citizen services whilst maintaining compliance with data protection regulations like GDPR. This seed round positions Guidoio amongst a growing cohort of European govtech startups attracting significant investment, suggesting that digitalising traditional government services represents a substantial opportunity for venture-backed companies willing to navigate regulatory complexity.

Fundraising
Fundraising
micronic printing manufacturing

European manufacturing is experiencing a precision revolution, driven by companies pushing the boundaries of what’s possible at the microscopic level. The latest player making waves is Hummink, which has raised €15 million to bring its micronic precision printing technology to advanced manufacturing sectors across Europe and beyond. The funding round was co-led by KBC Focus Fund, Cap Horn, and Bpifrance, marking a significant vote of confidence in Hummink’s approach to ultra-precise manufacturing. This investment positions the company at the forefront of Europe’s push toward next-generation manufacturing capabilities that could reshape industries from electronics to biotechnology. Strategic investors back micronic printing innovation The investor consortium reflects the strategic importance of Hummink’s technology. KBC Focus Fund, known for backing deep-tech companies with manufacturing applications, brings expertise in scaling hardware innovations across European markets. Cap Horn’s participation signals private equity confidence in the company’s commercial trajectory, while Bpifrance’s involvement underscores French government support for advanced manufacturing technologies. “Hummink’s micronic precision printing represents a fundamental shift in how we approach manufacturing at the smallest scales,” said a representative from the lead investor group. “Their technology addresses critical bottlenecks in sectors where precision isn’t just important—it’s everything.” The funding comes at a time when European manufacturers are increasingly seeking alternatives to traditional production methods, driven by sustainability concerns and the need for greater precision in emerging technologies like quantum computing and advanced sensors. Micronic precision meets manufacturing demands Hummink’s technology enables printing at the micronic level—thousands of times smaller than traditional manufacturing processes allow. This capability opens possibilities in sectors where Europe has strategic advantages, including automotive sensors, medical devices, and renewable energy components. The company plans to use the €15 million to scale its production capabilities and expand into new European markets, with particular focus on Germany’s automotive sector and the Netherlands’ high-tech manufacturing cluster. This European-first approach positions Hummink to capture value from the EU’s €43 billion advanced manufacturing market. “We’re not just improving existing processes—we’re enabling entirely new categories of products that weren’t possible before,” explains Hummink’s leadership team. “Our micronic printing technology allows manufacturers to achieve precision levels that bridge the gap between traditional manufacturing and nanotechnology.” The timing aligns with the European Union’s push for manufacturing sovereignty, particularly in high-precision components that have traditionally been dominated by Asian suppliers. Hummink’s technology could help European manufacturers reduce dependencies while achieving superior precision standards. This funding round signals growing investor confidence in European deep-tech companies that combine breakthrough innovation with clear commercial applications. As manufacturing continues its digital transformation, Hummink’s micronic precision printing technology positions Europe at the cutting edge of next-generation production capabilities.

Fundraising

Subscribe to
our Newsletter!

Stay at the forefront with our curated guide to the best upcoming Tech events.